Crossmark

Enhancer and metabolic rewiring by KMT2C–COMPASS or KMT2D–COMPASS family loss in cancer creates druggable vulnerabilities

Crossref DOI link: https://doi.org/10.1038/s41568-026-00919-x

Published Online: 2026-04-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Zibo

Shilatifard, Ali https://orcid.org/0000-0002-7490-2854
License Information

Text and Data Mining valid from 2026-04-24

Version of Record valid from 2026-04-24
More Information

Article History

Accepted: 25 February 2026

First Online: 24 April 2026

Competing interests

: Authors declare that they have no competing interests.